Autoantibodies in hospitalised patients with COVID‐19
Abstract Objectives CD209L and its homologous protein CD209 act as alternative entry receptors for the SARS‐CoV‐2 virus and are highly expressed in the virally targeted tissues. We tested for the presence and clinical features of autoantibodies targeting these receptors and compared these with autoa...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2024-01-01
|
| Seri Bilgileri: | Clinical & Translational Immunology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/cti2.70019 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|